These results indicate that AhR has a central role in lung carcinogenesis and may serve as a therapeutic/chemopreventive target for lung cancer, confirmed by the findings that deficiency in AhR inhibited BaP-induced lung cancer in vivo (Wang et al. 2019). This evidence concerns the gene AHR and lung cancer.